262 related articles for article (PubMed ID: 12432571)
1. Feto-maternal microchimerism in connective tissue diseases.
Gannagé M; Amoura Z; Lantz O; Piette JC; Caillat-Zucman S
Eur J Immunol; 2002 Dec; 32(12):3405-13. PubMed ID: 12432571
[TBL] [Abstract][Full Text] [Related]
2. Fetal cell microchimerism in tissue from multiple sites in women with systemic sclerosis.
Johnson KL; Nelson JL; Furst DE; McSweeney PA; Roberts DJ; Zhen DK; Bianchi DW
Arthritis Rheum; 2001 Aug; 44(8):1848-54. PubMed ID: 11508438
[TBL] [Abstract][Full Text] [Related]
3. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma.
Nelson JL; Furst DE; Maloney S; Gooley T; Evans PC; Smith A; Bean MA; Ober C; Bianchi DW
Lancet; 1998 Feb; 351(9102):559-62. PubMed ID: 9492775
[TBL] [Abstract][Full Text] [Related]
4. Persisting fetal microchimerism does not interfere with forensic Y-chromosome typing.
Klintschar M; Schwaiger P; Regauer S; Mannweiler S; Kleiber M
Forensic Sci Int; 2004 Jan; 139(2-3):151-4. PubMed ID: 15040908
[TBL] [Abstract][Full Text] [Related]
5. HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals.
Artlett CM; O'Hanlon TP; Lopez AM; Song YW; Miller FW; Rider LG
Arthritis Rheum; 2003 Sep; 48(9):2567-72. PubMed ID: 13130476
[TBL] [Abstract][Full Text] [Related]
6. Fetal microchimerisms in the mother: immunologic implications.
Tanaka A; Lindor K; Ansari A; Gershwin ME
Liver Transpl; 2000 Mar; 6(2):138-43. PubMed ID: 10719011
[TBL] [Abstract][Full Text] [Related]
7. Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma.
Lambert NC; Erickson TD; Yan Z; Pang JM; Guthrie KA; Furst DE; Nelson JL
Arthritis Rheum; 2004 Mar; 50(3):906-14. PubMed ID: 15022334
[TBL] [Abstract][Full Text] [Related]
8. Detection of maternal DNA in umbilical cord blood by polymerase chain reaction amplification of minisatellite sequences.
Briz M; Regidor C; Monteagudo D; Somolinos N; Garaulet C; Forés R; Posada M; Fernández MN
Bone Marrow Transplant; 1998 Jun; 21(11):1097-9. PubMed ID: 9645571
[TBL] [Abstract][Full Text] [Related]
9. Pregnancy immunology and autoimmune disease.
Nelson JL
J Reprod Med; 1998 Apr; 43(4):335-40. PubMed ID: 9583065
[TBL] [Abstract][Full Text] [Related]
10. [Pregnancy, micro-chimerism and autoimmune diseases].
Nowakowska B
Postepy Hig Med Dosw; 2002; 56(2):127-37. PubMed ID: 12107958
[TBL] [Abstract][Full Text] [Related]
11. [Microchimerisme in systemic sclerosis].
Aractingi S; Regnier S
Ann Med Interne (Paris); 2002 May; 153(3):189-91. PubMed ID: 12218902
[TBL] [Abstract][Full Text] [Related]
12. Detection of cellular microchimerism of male or female origin in systemic sclerosis patients by polymerase chain reaction analysis of HLA-Cw antigens.
Artlett CM; Cox LA; Jimenez SA
Arthritis Rheum; 2000 May; 43(5):1062-7. PubMed ID: 10817560
[TBL] [Abstract][Full Text] [Related]
13. Direct quantification of fetal cells in maternal blood by real-time PCR.
Zhong XY; Holzgreve W; Hahn S
Prenat Diagn; 2006 Sep; 26(9):850-4. PubMed ID: 16821250
[TBL] [Abstract][Full Text] [Related]
14. Feasibility study of using fetal DNA in maternal plasma for non-invasive prenatal diagnosis.
Liu FM; Wang XY; Feng X; Wang W; Ye YX; Chen H
Acta Obstet Gynecol Scand; 2007; 86(5):535-41. PubMed ID: 17464580
[TBL] [Abstract][Full Text] [Related]
15. [Study on fetal SRY gene in maternal plasma using nested polymerase chain reaction].
Hong P; Zhu PY; Huang YF; Luan JF
Zhonghua Nan Ke Xue; 2006 Apr; 12(4):333-6. PubMed ID: 16683567
[TBL] [Abstract][Full Text] [Related]
16. Quantification of fetal microchimeric cells in clinically affected and unaffected skin of patients with systemic sclerosis.
Sawaya HH; Jimenez SA; Artlett CM
Rheumatology (Oxford); 2004 Aug; 43(8):965-8. PubMed ID: 15199216
[TBL] [Abstract][Full Text] [Related]
17. [Microchimerism--a possible cause of autoimmune disease?].
Grauslund J; Wang P
Ugeskr Laeger; 2004 Aug; 166(34):2882-5. PubMed ID: 15449524
[No Abstract] [Full Text] [Related]
18. A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.
Bauer M; Hutterer G; Eder M; Majer S; Leshane E; Johnson KL; Peter I; Bianchi DW; Pertl B
Prenat Diagn; 2006 Sep; 26(9):831-6. PubMed ID: 16832830
[TBL] [Abstract][Full Text] [Related]
19. Long-term feto-maternal microchimerism: nature's hidden clue for alternative donor hematopoietic cell transplantation?
Ichinohe T; Maruya E; Saji H
Int J Hematol; 2002 Oct; 76(3):229-37. PubMed ID: 12416733
[TBL] [Abstract][Full Text] [Related]
20. Male microchimerism and HLA compatibility in French women with sclerodema: a different profile in limited and diffuse subset.
Rak JM; Pagni PP; Tiev K; Allanore Y; Farge D; Harlé JR; Launay D; Hachulla E; Didelot R; Cabane J; Kahan A; Martin M; Granel B; Roudier J; Lambert NC
Rheumatology (Oxford); 2009 Apr; 48(4):363-6. PubMed ID: 19208687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
